StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$101.80+0.08 (+0.08%)

Close on Nov 17, 2026Market cap $6.64BP/E 24.6Yield –

Lantheus market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lantheus's market cap was $6.63B on Nov 11, 2026, against $4.23B a year earlier. Over the last 5 years it ranged from $1.72B to $7.77B, with a median of $5.10B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.63B+38.8%
2025Dec 31, 2025$4.78B-24.6%
2024Dec 31, 2024$6.34B+46.5%
2023Dec 29, 2023$4.33B+23.4%
2022Dec 30, 2022$3.51B+79.4%
2021Dec 31, 2021$1.95B+116.8%
2020Dec 31, 2020$901.81M+12.1%
2019Dec 31, 2019$804.59M+33.7%
2018Dec 31, 2018$601.95M-21.5%
2017Dec 29, 2017$766.83M+149.7%
2016Dec 30, 2016$307.15M+199.3%
2015Dec 31, 2015$102.63M–

More Lantheus figures

See a number that looks wrong?